Wall Street Analysts Think Stoke Therapeutics (STOK) Could Surge 132.4%: Read This Before Placing a Bet

Stoke Therapeutics, Inc. (STOK) closed the last trading session at $9.63, gaining 25.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 22.38 indicates a 132.4% upside potential.The average comprises eight short-term price targets ranging from a low of $15 to a high of$ 35, with a standard deviation of $6.82. While the lowest estimate indicates an increase of 55.8% from the curren ...